Azitra, Inc. announced a reverse stock split of its common stock at a ratio of 1 post-split share for every 6.66 pre-split shares. The reverse stock split will become effective on August 21, 2025. The company's common stock will continue to be traded on the NYSE American under the symbol "AZTR" and will begin trading on a split-adjusted basis when the market opens on August 21, 2025.
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, has announced a reverse stock split of its common stock at a ratio of 1 post-split share for every 6.66 pre-split shares. The reverse stock split will become effective on August 21, 2025. The company's common stock will continue to be traded on the NYSE American under the symbol "AZTR" and will begin trading on a split-adjusted basis when the market opens on August 21, 2025 [1].
The reverse stock split will reduce the number of issued shares of Azitra's common stock from 23,476,354 shares to approximately 3,524,978 shares. At the effective time of the reverse stock split, every 6.66 shares of the Company's issued common stock will be converted automatically into one issued share of common stock without any change in the par value per share. Stockholders holding shares through a brokerage account will have their shares automatically adjusted to reflect the 1-for-6.66 reverse stock split [1].
The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. No fractional shares of common stock will be issued in connection with the reverse split. Stockholders of record who otherwise would be entitled to receive fractional shares, will be entitled to receive cash (without interest) in lieu of fractional shares, equal to such fraction multiplied by the average of the closing sales prices of the common stock on the NYSE American during regular trading hours for the five consecutive trading days immediately preceding the effective date of the reverse split (with such average closing sales prices being adjusted to give effect to the reverse split) [1].
Azitra's 1:6.66 reverse split aims to boost share price but signals potential financial concerns without addressing fundamental business issues. The unusually precise split ratio of 1:6.66 suggests that Azitra is targeting a particular post-split share price, likely to meet the NYSE American's continued listing requirements which mandate a minimum share price (typically $1.00) [2].
The timing of the split is also notable. Azitra obtained shareholder approval back in February but waited six months to implement it. This delay suggests management may have been hoping for organic share price recovery that never materialized, forcing their hand with this financial engineering solution [2].
References:
[1] https://www.prnewswire.com/news-releases/azitra-inc-announces-reverse-stock-split-302526802.html
[2] https://www.stocktitan.net/news/AZTR/azitra-inc-announces-reverse-stock-kwjsmbmwdlyz.html
Comments
No comments yet